Long Ideas - Sarepta Therapeutics (SRPT) has become a bit of a lightning rod, with the company’s shares trading near the middle of their 52-week range (from $3.30 … Continue Reading
Read NowLong Ideas - In late November, PropThink wrote about Anthera Pharmaceuticals (ANTH), noting that the company’s lead drug candidate, blisibimod (or B-mod), has promise for the treatment of … Continue Reading
Read NowLong Ideas - Shares of ISIS Pharmaceuticals (ISIS) were up over 8% at the close of trading on Monday, just days ahead of the American Association of Neurology … Continue Reading
Read NowLong Ideas - Sarepta (SRPT) announced Monday that results from a non-human primate study of AVI-7288, the company’s lead drug candidate for the treatment of Marburg virus infection, … Continue Reading
Read NowLong Ideas - With a broad 12-asset pipeline, Immunomedics (IMMU), at first glance, lacks focus. But a closer look reveals a diverse development program supported by solid clinical … Continue Reading
Read NowLong Ideas - The Bears may focus on the pushes and pulls around Questcor Pharmaceuticals’ (QCOR) 4Q 2012 earnings results, but the bottom line is, the earnings results … Continue Reading
Read NowLong Ideas - Endo Pharmaceuticals (ENDP) named its new CEO Monday morning, Rajiv De Silva, who was formerly President and COO of Valeant Pharmaceuticals (VRX). In a January … Continue Reading
Read Now